X0306
4
2018-01-16
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001343124
OBrien Christopher Flint
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
0
1
0
0
Chief Medical Officer
Common Stock
2018-01-16
4
S
0
1750
79.1423
D
50723
D
Sale of 1,750 shares of common stock issued upon vesting of 3,500 restricted stock units on January 16, 2018 to cover payroll and withholding taxes, with the balance of the shares (1,750) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in
a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the
Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $76.09 to $82.04. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
/s/ Darin Lippoldt, Attorney-in-Fact
2018-01-18